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ABSTRACT 
Pharmacological evidence is presented  for the involvement of microtubules in the 
process of fast  axoplasmic transport.  A  quantitative  measure  of the inhibition of 
axoplasmic transport in an in vitro preparation of rat sciatic nerve is described. The 
alkaloids colchicine,  podophyllotoxin,  and  vinblastine,  which  are  known  both  to 
disrupt  microtubules  and  to  bind  to  the  protein  subunit  of  microtubules,  are 
inhibitors  of axoplasmic transport.  Lumicolchicine  and  picropodophyllin, unlike 
their  respective  isomers  colchicine  and  podophyllotoxin,  are  poor  inhibitors  of 
axoplasmic  transport.  The  dissociation  constants  for  the  binding  of colchicine, 
lumicolchicine,  podophyllotoxin,  and  picropodophyllin  to  purified  microtubule 
protein from  rat brain have been  measured.  Inhibition of axoplasmic transport by 
these drugs correlates favorably with their affinities for microtubule protein. 
The  movement  of material from  a  neuronal  cell 
body  through  its  axon  toward  nerve  endings  is 
called axoplasmic transport. This process is char- 
acterized in  mammalian  nerves by a  slow rate of 
1-3 mm/day and a fast rate of 100  400 mm/day. 
Ochs  and  Smith  (15)  have  used  inhibitors  of 
glycolysis and  oxidative phosphorylation to dem- 
onstrate that energy for fast axoplasmic transport 
is generated locally along the nerve.  Little else is 
known concerning the molecular mechanics of the 
transport process. 
Schmitt  (20)  has  suggested  that  microtubules 
might be involved in the process of fast axoplasmic 
transport.  Microtubules,  which  are  found  in  all 
axons,  are  thought  to  run  in  a  continuous  un- 
branched  fashion from the nerve cell body to the 
nerve  ending.  The  primary  evidence  for  the  in- 
volvement of microtubules in axoplasmic transport 
is  the  inhibition  of  the  transport  process  by 
colchicine and  vinblastine  (See  review,  reference 
12). These  two  drugs  are  known  to  disrupt  mi- 
crotubules in axons (30) and to hind to tubulin, the 
protein subunit of microtubules (3, 26). Colchicine 
and  vinblastine,  however,  interact  with  proteins 
other than  microtubule protein, and inhibit proc- 
esses not mediated by microtubules (9,  11,  14, 25, 
27). Furthermore, electron micrographic studies of 
nerves  in  which  transport  had  been  inhibited  by 
colchicine reveal microtubules which  appear nor- 
mal (10).  Finally, silver grains in electron micro- 
scope  autoradiographs  of  axons  through  which 
tritiated  proteins  were  being  carried  by  rapid 
axoplasmic  transport  lie  near  the  axonal  mem- 
brane (6, 4).  In contrast, microtubules are distrib- 
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In  view  of  the  observations  cited  above,  we 
wished  to  examine  further  the  hypothesis  that 
microtubules  are  involved  in  the  process  of axo- 
plasmic  transport.  To  test  whether  inhibition  of 
transport by colchicine and vinblastine is mediated 
by  a  specific  action  on  microtubules,  we  have 
considered  three  additional  pharmacological 
agents:  lumicolchicine,  podophyllotoxin,  and  pi- 
cropodophyllin.  Lumicolchicine,  a  structural  iso- 
mer of colchicine, has been shown to have little or 
no affinity for  microtubule  protein (3,  29).  Lumi- 
colchicine does  not  inhibit the action  of vasopres- 
sin,  while  colchicine  is  a  potent  inhibitor  (24). 
Nucleoside  uptake  in  HeLa  ceils,  however,  is 
inhibited just as effectively  by lumicolchicine as it 
is  by colchicine (14).  Differential activity of these 
two drugs in the first case suggests the involvement 
of microtubules,  while a  lack  of differential activ- 
ity  in the second case  may  represent  an  action  of 
colchicine not  related to  binding to  microtubules. 
Podophyllotoxin  and  its diastereomer,  picropodo- 
phyllin, may also be used as probes of microtubule 
function.  Podophyllotoxin has been shown to com- 
pete  with  colchicine  for  binding  to  microtubule 
protein (3, 29). Picropodophyllin is less effective as 
a  competitive  inhibitor of colchicine binding (13, 
29).  These two pairs of isomers have been studied 
as inhibitors of fast axoplasmic transport  in an in 
vivo  system  employing  the  rat  optic  nerve  (18). 
Inhibition  of  transport  by  colchicine  and  podo- 
phyllotoxin,  and  lack  of inhibition by lumicolchi- 
cine  and  picropodophyllin,  is  consistent  with  the 
involvement of microtubules  in axoplasmic trans- 
po ft. 
In  this paper  we  have extended  the  pharmaco- 
logical  evidence  for  the  involvement  of  mi- 
crotubules  in  fast  axoplasmic  transport.  In  order 
to allow  quantitative comparison  of inhibitors, an 
in  vitro  system  with  which  to  study  axoplasmic 
transport has been used.  Several agents have been 
tested both as inhibitors in this in vitro system and, 
in a  companion study (13),  as ligands for binding 
to  isolated  microtubule  protein  from  rat  brain. 
Inhibition of axoplasmic transport by these agents 
reflects their relative affinity for microtubule pro- 
tein. 
MATERIALS  AND  METHODS 
Qualitative  studies  of  the  drug-induced  inhibition  of 
rapid axoplasmic transport in rat sciatic nerve have been 
described  (5,  19).  A  sciatic  nerve with  the  L6  and  L7 
dorsal  root ganglia attached is dissected from a  female 
rat  anesthetized  with  pentobarbital and  urethane.  The 
nerve  is  placed  on  the  bottom  of  a  rectangular  box 
separated into three cells by slotted partitions (Fig.  1  ). By 
means of grease seals built up around the nerve at the 
partitions, the cells are isolated from each other.  After 
covering the nerve with TC medium 199 or Krebs-Ringer 
solution (supplemented with glucose,  I g/liter), the box is 
incubated at 37~  in 95% O2-5% CO2.  L-[3H]Proline is 
introduced  into  the  first  cell,  which  contains  the  two 
ganglia. Proteins labeled with tritium are synthesized by 
the  nerve cell  bodies,  transported down  the nerve, and 
accumulate at a ligation placed on the nerve in the third 
cell.  The second cell (of about  1 ml volume) is continu- 
ously perfused with fresh medium (4 ml/h) to wash out 
any  free  L-[3H]proline that might leak  past the grease 
seal.  After  12-16 h, the nerve is fixed  in 5% trichloro- 
acetic acid to remove any free tritiated proline (8)  and 
is cut into  1-mm  sections. Since treatment with trichlo- 
roacetic acid shrinks the  nerve by 50%,  1-mm  sections 
of the treated nerves represent 2 mm of the fresh tissue. 
Sections were solubilized with Soluene-100 and counted 
in  a  Beckman  LS-230  liquid  scintillated  spectrometer 
after addition of scintillation cocktail (1). 
Materials 
Female  rats of the  NLR  strain were  procured  from 
National  Laboratories,  St  Louis,  Mo.  L-[2,3- 
3H]proline  ￿9 HC1 was obtained from New England Nu- 
clear, Boston, Mass. at a specific activity of 35 Ci/mmol 
and a concentration of 10 mCi/ml. The tissue solubilizer, 
Soluene-100,  was  purchased  from  Packard  Instrument 
Co.,  Downers Grove,  Ill.  In vitro nerve chambers were 
cast from Sylgard  185 (Dow Corning, Midland, Mich.). 
TC medium  199 was obtained from Difco Laboratories, 
Detroit, Mich. Vinblastine sulfate was a gift of Eli Lilly 
and Co., Indianapolis, lnd. Picropodophyllin was kindly 
donated  by  Prof.  E.  Smissman.  Podophyllotoxin  was 
obtained  from  Delta  Scientific Corp.,  Lindenhurst, N. 
Y., and colchicine from Sigma Chemical Co., St. Louis, 
Mo. The picropodophyllin and podophyllotoxin used  in 
this paper have chemical structures defined in a series of 
papers by Schrecker and Hartwell (21), and should not be 
confused with podophyllin, which is crude extract from 
which both compounds can be isolated. A mixture of ~- 
and 7-1umicochicine (referred to in this paper as lumicol- 
chicine) was prepared from colchicine by the method of 
Wilson and  Friedkin (28).  Characterization of lumicol- 
chicine is presented elsewhere (13). 
RESULTS 
Using an in vitro preparation of rat sciatic nerve, a 
typical  transport  profile  of  protein  labeled  with 
tritiated proline is presented in Fig.  1. A prominent 
peak  of accumulated  radioactivity appears  proxi- 
mal  to  a  ligation  (arrow)  which  is  placed  on  the 
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In vitro axoplasmic transport  through  sen- 
sory fibers of the rat sciatic nerve. Profile of transported 
radioactivity from a nerve is plotted as dpm/mm of nerve 
vs. distance from the L6 ganglion. Solid blocks represent 
the position of the grease seals  placed  between  cells.  A 
ligation (arrow) is placed on the nerve in the third cell. 
No  drugs  were  present.  Details  of the  experiment  are 
given in Methods. 
nerve in the third cell. Although the slight peak of 
radioactivity  at  the  grease  seal  was  sometimes 
seen, in six control nerves it was never larger, with 
respect  to  the  peak  at  the  ligation,  than  that 
depicted  in  Fig.  1.  If a  nerve in which  the ganglia 
were  removed  is  incubated  in  this  system,  no 
tritiated  proteins  are  transported  past  the  first 
grease  seal  (19).  The  presence  of an  inhibitor  of 
protein synthesis (I mM cycloheximide) in the first 
cell  will  also  prevent  the  appearance  of  any 
transported  radioactivity in the nerve, although the 
same  drug  has  no  effect  upon  transport  when 
placed in either or both of the two remaining cells 
(data  not shown). 
To test an inhibitor of axoplasmic transport,  the 
drug  is dissolved in the medium  bathing the nerve 
in the third  cell.  In this manner,  only the nerve in 
the  third  cell  is  exposed  to  compound  being 
studied.  Inhibition  of transport  is detected  by  an 
increase  in  the  tritium  which  accumulates  in  the 
nerve  at  the  entrance  to  the  third  cell,  and  a 
corresponding  decrease  in the peak  of material  at 
the ligation.  Maximal  inhibition  is observed when 
no transported  radioactivity enters the third  cell. 
Three  plant  alkaloids  known  to  disrupt  mi- 
crotubules  (26,  30)  were  studied  in  this  system. 
Colchicine, vinblastinr  and  podophyllotoxin were 
found to  be potent inhibitors of axoplasmic trans- 
port.  Transport  profiles demonstrating equivalent, 
but not complete inhibition are shown  (Fig. 2). 
Lumicolchicine  (3,  29)  and  picropodophyllin 
(29)  bind  less tightly  to  microtubule  protein  than 
do  their  respective  isomers,  colchicine and  podo- 
phyllotoxin.  When  tested  at  concentrations  near 
their  limits of solubility,  these  agents  gave trans- 
port  profiles  indistinguishible  from  controls  in 
which  no drug  was present  (Fig.  3). 
The  preceding  experiments  may  be  compared 
quantitatively  by expressing the amount  of radio- 
activity transported  into the third cell as a percent- 
age of the total  radioactivity transported  into the 
second  and  third  cells.  In  practice,  when  an 
inhibitor  was  placed  in  the  third  cell the  peak  of 
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FIGURE  2  Inhibition  of  axoplasmic  transport  by  mi- 
crotubule disruptive agents.  Examples of transport  pro- 
files obtained in the presence  of vinblastine (10 pM, top 
frame),  colchicine (100  pM,  middle frame), and  podo- 
phyllotoxin (I  pM,  bottom  frame) are shown.  In each 
case the drug was dissolved  in the medium bathing the 
nerve in the third cell. Data from the first cell have been 
omitted  as they contain  no information  relating to the 
inhibition  of transport  by a drug placed in the third cell. 
See Fig.  1. 
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grease seal extended 4 mm into the third chamber. 
Therefore,  the  radioactivity  in  the  two  sections 
distal to the second grease seal was not included as 
material  transported  into  the  third  cell.  In  six 
control experiments  with  no test compound  in the 
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FIGURE  3  Lack  of inhibition  of transport  by lumicol- 
chicine and  picropodophyllin. The drugs were present  in 
the third cell, at the given concentrations.  For details see 
the captions to Figs.  1 and  2. 
third  cell,  the  percentage  of  the  radioactivity 
transported  past  the  second  grease  seal  (%P)  was 
28.8  i  8.0.  A  net  transport  value  (NT)  may  be 
calculated  for experiments  involving inhibitors: 
%P (experimental) 
NT  - 
%P (control) 
Compounds  which  did  not  inhibit  would  produce 
an  NT value of  1.00,  while those giving complete 
inhibition  would  produce  a  value of 0.00.  Values 
between  these  extremes  would  indicate  partial 
inhibition. 
By  this  method,  data  for  five compounds  have 
been summarized in Fig. 4. Vinblastine, colchicine, 
and  podophyllotoxin  produce  a  dose-related  inhi- 
bition  of  fast  axoplasmic  transport.  In  contrast, 
lumicolchicine and picropodophyllin are not active 
at  the  highest  doses  allowed  by  the  solubility  of 
these compounds. 
In  the  experiments  presented  above,  colchicine 
never  inhibited  transport  completely.  It  has  been 
shown  that  maximal  sensitivity  of  axoplasmic 
transport  to colchicine requires exposures  of long 
duration  ([0,  18). To establish  in this system  that 
colchicine  is  more  active  after  preincubation, 
nerves  were  incubated  with  the  drug  in  the  third 
cell before introducing  L-[3H]proline  into the first 
cell. 6 h of preincubation  increase the efficiency of 
colchicine as an  inhibitor of axoplasmic transport 
by  a  factor  of  about  10  (Fig.  5).  Under  these 
conditions  a  concentration  of  100  #M  produces 
nearly  complete  inhibition.  A  strong  block  of 
transport  is  seen  even  at  10 #M,  a  concentration 
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FIGURE 4  Dose  response  curves of several  agents as  inhibitors of axoplasmic transport.  O, Podophyl- 
Iotoxin;  E),  picropodophyllin:  I-I  vinblastine;  I,  colchicine;  and  A,  lumicolchicine.  Each  point  is  the 
average of two or three experiments. The range of values about each point is typically :~0.10  0.15.  See 
discussion  of net transport  value (NT) in Results. 
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FIGURE 5  Increased  inhibition by colchicine and lumi- 
colchicine with 6-h  preincubation.  Colchicine: II,  no 
preincubation; r-I, 6-h preincubation. Lumicolchicine:  A, 
no preincubation; A, 6-h preincubation. Each point is the 
average of two or three experiments. The range of values 
about each point  is typically •  For clarity, 
data with no preincubation are repeated from Fig. 4. See 
discussion of the net transport value  (NT) in Results. 
TABLE  1 
Correlation  for  Several  Ligands  of Affinity for 
Microtubule  Protein and Inhibition  of Axoplasmic 
Transport 
Concentration | 
Agent  K diss*  NT = 0.55 
t~M  uM 
No preincubation 
Colchicine  0.063  36 
Lumicolchicine  1,570  No inhibition ~  1,000 
Podophyllotoxin  0.28  0.5 
Picropodophyllin  37.8  No inhibition ~  1,000 
Vinblastine  --  1. I 
6-h preincubation 
Colchicine  0.063  2.9 
Lumicolchicine  1,570  No inhibition ~  1,000 
* Values from reference 13. 
:~ Values interpolated  from Figs. 4 and 5. 
which produced very little effect  without preincu- 
bation. 
In  a  companion study  to  this  paper  we  have 
determined the dissociation constants for the bind- 
ing of colchicine, lumicolchicine, podophyllotoxin, 
and picropodophyllin to microtubule protein puri- 
fied  from  rat  brain  (13).  Barring  problems  of 
permeability into  the  nerve  tissue,  inhibition of 
axoplasmic  transport  by  these  drugs  might  be 
expected to correlate with their strength of binding 
to microtubule protein. A comparison of these two 
parameters is presented in Table 1. Colchicine and 
podophyllotoxin are over 100 times more effective 
as inhibitors of axoplasmic transport than are their 
respective isomers, lumicolchicine and picropodo- 
phyllin. Colchicine binds microtubule protein with 
an affinity 25,000 times that of lumicolchicine, and 
podophyllotoxin binds 135 times more tightly than 
does picropodophyllin. The differential activity of 
these  two  pairs  of  isomers  as  ligands  for  mi- 
crotubule  protein  and  inhibitors  of  axoplasmic 
transport  is  consistent  with  the  suggestion  that 
colchicine,  podophyllotoxin,  and  vinblastine in- 
hibit  transport  through  their  binding  to  mi- 
crotubule protein. 
DISCUSSION 
Evidence presented in this communication suggests 
that microtubules are in some way required for the 
process of rapid axoplasmic transport. Colchicine 
and podophyllotoxin are at least  100 times more 
active than their respective isomers, lumicolchicine 
and  picropodophyllin, both  as  inhibitors of axo- 
plasmic  transport  and  as  ligands  for  purified 
microtubule  protein,  in  addition,  vinblastine, 
which  binds  porcine  brain  microtubule  protein 
with  an equilibrium constant of 0.17  uM  (2,  17, 
23),  is a potent inhibitor of axoplasmic transport. 
While a good qualitative correlation exists between 
the affinity of these agents for microtubule protein 
and their potency as antitransport agents, the lack 
of a more quantitative correlation is not surprising. 
The fact that colchicine is a more potent inhibitor 
of transport with increasing periods of incubation 
with the nerve suggests that equilibrium within the 
cell  between  colchicine  and  microtubule protein 
may  not be  established during the  time of these 
experiments. 
The actual role of microtubules in the molecular 
mechanism of axoplasmic transport  is  not clear. 
As  originally suggested  by  Schmitt  and Samson 
(20),  materials carried by axoplasmic flow may be 
packaged  in vesicles  which  move down the  axon 
through  a  mechanochemical  coupling  to  mi- 
crotubules. The only clear demonstration of vesi- 
cle-microtubule  interaction  which  has  been  re- 
ported,  however,  in  axons  in  the  spinal cord  of 
Petromyzon  marinus  (22).  Recently, it  has  been 
shown that  movement of protein and particles in 
membranes is inhibited in a number of systems by 
colchicine, vinblastine, and podophyllotoxin (7, 16, 
31).  In  one case,  inhibition of the  movement of 
concanavalin  A  receptors  by  colchicine  is  not 
mimicked by an equivalent dose of lumicolchicine 
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ity  that  microtubules,  or  a  protein  similar  to 
microtubule  protein,  play  a  role  in  the  lateral 
movement of material in  membranes of axons.  If 
so, the movement of materials by fast axoplasmic 
transport  may  occur  in  some  type  of membrane 
element which runs continously from the nerve cell 
body to the synaptic ending. Such a  membranous 
element could be either the axolemma itself, or the 
smooth endoplasmic reticulum. 
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